zidovudine has been researched along with r-82913 in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 16 (94.12) | 18.2507 |
2000's | 1 (5.88) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Breslin, HJ; De Clercq, E; Diamond, CJ; Grous, PP; Ho, CY; Kukla, MJ; Miranda, M; Pauwels, R; Rodgers, JD; Sherrill, RG | 1 |
Andreola, ML; Aubertin, AM; Bisagni, E; Dollé, V; Fan, E; Jamieson, G; Kirn, A; Nguyen, CH; Tarrago-Litvak, L | 1 |
Antonenko, SV; Chentsova, NP; Kukhar, VP; Luik, AI; Poda, GI; Tetko, IV | 1 |
Balani, SK; Ciccarone, TM; Condra, JH; Emini, EA; Goldman, ME; Greenlee, WJ; Kauffman, LR; MacTough, SC; Rooney, CS; Williams, TM | 1 |
Breslin, HJ; De Clercq, E; Diamond, CJ; Grous, PP; Ho, CY; Ho, W; Kukla, MJ; Ludovici, DW; Miranda, M; Rodgers, JD | 1 |
Bell, FW; Cantrell, AS; Högberg, M; Jaskunas, SR; Johansson, NG; Jordan, CL; Kinnick, MD; Lind, P; Morin, JM; Noréen, R | 1 |
Andreola, ML; Aubertin, AM; Bisagni, E; Dollé, V; Kirn, A; Legraverend, M; Nguyen, CH; Tarrago-Litvak, L; Ventura, M | 1 |
Larder, BA | 1 |
Andries, K; De Clercq, E; Debyser, Z; Pauwels, R | 1 |
Balzarini, J; Bergamini, A; Calio, R; De Clercq, E; Milanese, G; Pauwels, R; Perno, CF; Rocchi, G; Yarchoan, R | 1 |
Anné, J; de Clercq, E; de Vreese, K; Debyser, Z; Desmyter, J; Pauwels, R; Vandamme, AM | 1 |
Andries, K; Buckheit, RW; Chirigos, MA; Germany, JM; Janssen, PA; Pauwels, R; Ross, LJ; Shannon, WM; White, EL | 1 |
Andries, K; Ganser, A; Geissler, RG; Hoelzer, D; Kojouharoff, G; Ottmann, OG; Reutzel, P; Schellekens, K | 1 |
Allen, LB; Buckheit, RW; Chirigos, MA; Germany-Decker, J; Hollingshead, MG; Janssen, PA; Shannon, WM | 1 |
Bakhanashvili, M; Hizi, A | 1 |
Hansen, JE; Mathiesen, LR; Nielsen, C; Nielsen, JO; Sørensen, AM | 1 |
Balzarini, J; De Clercq, E; Kleim, JP; Pelemans, H; Riess, G; Roesner, M; Winkler, I | 1 |
1 review(s) available for zidovudine and r-82913
Article | Year |
---|---|
Specific HIV-1 reverse transcriptase inhibitors.
Topics: Antiviral Agents; Benzodiazepines; HIV Reverse Transcriptase; HIV-1; Imidazoles; Models, Genetic; Reverse Transcriptase Inhibitors; Thymine; Transcription, Genetic; Zidovudine | 1992 |
16 other study(ies) available for zidovudine and r-82913
Article | Year |
---|---|
Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-on e (TIBO) derivatives. 2.
Topics: Antiviral Agents; Benzodiazepines; HIV-1; Imidazoles; Microbial Sensitivity Tests; Structure-Activity Relationship; Virus Replication | 1991 |
A new series of pyridinone derivatives as potent non-nucleoside human immunodeficiency virus type 1 specific reverse transcriptase inhibitors.
Topics: Antiviral Agents; HIV Reverse Transcriptase; HIV-1; HIV-2; Kinetics; Molecular Structure; Pyridones; Recombinant Proteins; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Structure-Activity Relationship; Virus Replication | 1995 |
HIV-1 reverse transcriptase inhibitor design using artificial neural networks.
Topics: Algorithms; Cell Line; Drug Design; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Structure; Neural Networks, Computer; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; T-Lymphocytes; Zidovudine | 1994 |
5-chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase.
Topics: Animals; Antiviral Agents; Base Sequence; Biological Availability; HIV; HIV Reverse Transcriptase; HIV-1; Indoles; Macaca mulatta; Molecular Sequence Data; Molecular Structure; Reverse Transcriptase Inhibitors; Sulfoxides | 1993 |
Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo-[4,5,1-jk][1,4]benzodiazepin- 2(1H)-one (TlBO) derivatives. 4.
Topics: Antiviral Agents; Benzodiazepines; Cell Line; Cytopathogenic Effect, Viral; HIV-1; Imidazoles; Structure-Activity Relationship; Virus Replication | 1995 |
Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT analogs.
Topics: Animals; Antiviral Agents; Cell Line; HIV-1; Humans; Isothiocyanates; Rats; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thiazoles; Thiourea | 1995 |
Synthesis and antiviral activity of 4-benzyl pyridinone derivatives as potent and selective non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; Cell Line; Cells, Cultured; Drug Resistance, Microbial; HIV-1; Humans; Pyridones; Recombinant Proteins; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Structure-Activity Relationship; Virion; Virus Replication | 2000 |
3'-Azido-3'-deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitors.
Topics: Antiviral Agents; Base Sequence; Benzodiazepines; Cloning, Molecular; Drug Resistance, Microbial; HIV Reverse Transcriptase; HIV-1; Humans; Imidazoles; Molecular Sequence Data; Mutagenesis, Site-Directed; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; Zidovudine | 1992 |
Different pattern of activity of inhibitors of the human immunodeficiency virus in lymphocytes and monocyte/macrophages.
Topics: Adenine; Antibodies, Viral; Antiviral Agents; Benzodiazepines; CD4 Antigens; Cytokines; Didanosine; Doxorubicin; Drug Interactions; HIV; HIV Infections; Humans; Imidazoles; Leukocytes, Mononuclear; Lymphocytes; Macrophages; Monocytes; Organ Specificity; Organophosphonates; Zalcitabine; Zidovudine | 1992 |
Resistance of human immunodeficiency virus type 1 reverse transcriptase to TIBO derivatives induced by site-directed mutagenesis.
Topics: Antiviral Agents; Base Sequence; Benzodiazepines; Binding Sites; Deoxyguanine Nucleotides; Dideoxynucleotides; HIV Reverse Transcriptase; HIV-1; Imidazoles; Molecular Sequence Data; Mutagenesis, Site-Directed; Oligodeoxyribonucleotides; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Structure-Activity Relationship; Uracil; Zidovudine | 1992 |
A TIBO derivative, R82913, is a potent inhibitor of HIV-1 reverse transcriptase with heteropolymer templates.
Topics: Base Sequence; Benzodiazepines; HIV-1; HIV-2; Imidazoles; Molecular Sequence Data; Retroviridae Proteins; Reverse Transcriptase Inhibitors; Templates, Genetic; Zidovudine | 1991 |
TIBO R82913, a new HIV-1 inhibiting agent, does not inhibit hematopoietic progenitor cells.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Benzodiazepines; Colony-Forming Units Assay; Erythroid Precursor Cells; Hematopoietic Stem Cells; Humans; Imidazoles; Zidovudine | 1991 |
Differential antiviral activity of two TIBO derivatives against the human immunodeficiency and murine leukemia viruses alone and in combination with other anti-HIV agents.
Topics: Animals; Antiviral Agents; Benzodiazepines; Cell Line; Didanosine; Drug Synergism; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Imidazoles; Mice; Rauscher Virus; Reverse Transcriptase Inhibitors; Virus Replication; Zidovudine | 1993 |
Interaction of the reverse transcriptase of human immunodeficiency virus type 1 with DNA.
Topics: Antiviral Agents; Autoradiography; Base Sequence; Benzodiazepines; Binding, Competitive; Dideoxynucleotides; DNA-Binding Proteins; DNA, Viral; Electrophoresis, Polyacrylamide Gel; HIV Reverse Transcriptase; HIV-1; Imidazoles; Molecular Sequence Data; Oligodeoxyribonucleotides; Quinolones; Recombinant Proteins; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Thymine Nucleotides; Zidovudine | 1994 |
Evaluation of the combination effect of different antiviral compounds against HIV in vitro.
Topics: Antiviral Agents; Benzodiazepines; Didanosine; Dideoxynucleosides; Drug Combinations; Drug Evaluation; Drug Synergism; HIV; Humans; Imidazoles; Microbial Sensitivity Tests; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 1993 |
Retention of marked sensitivity to (S)-4-isopropoxycarbonyl-6-methoxy-3-(methylthiomethyl)-3,4-di hydroquin oxaline-2(1H)-thione (HBY 097) by an azidothymidine (AZT)-resistant human immunodeficiency virus type 1 (HIV-1) strain subcultured in the combined
Topics: Anti-HIV Agents; Antiviral Agents; Benzodiazepines; Cell Line; Delavirdine; Drug Resistance, Microbial; Furans; HIV Reverse Transcriptase; HIV-1; Humans; Imidazoles; Lamivudine; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Mutation; Nevirapine; Quinoxalines; Recombinant Proteins; Reverse Transcriptase Inhibitors; Zidovudine | 1998 |